United States-based CVS Health (NYSE: CVS) is to provide COVID-19 vaccinations to long-term care facilities throughout the United States when a vaccine becomes available, it was reported on Friday.
CVS Health says that it has the experience and expertise to play a vital role in the COVID-19 vaccination effort. It quickly mobilised its colleagues and resources to provide COVID-19 testing sites in the country and have now administered over five million COVID tests.
Troyen Brennan, MD, chief medical officer, CVS Health, said, 'CVS Health has been on the front lines of the fight against COVID-19, working across the health care spectrum in all the communities we serve and that will continue to be the case when we have a vaccine to administer. Our nation's elderly living in long-term care facilities are one of the most vulnerable populations. With early access to a vaccination, we can help keep them, and the staff caring for them, healthy and safe.'
Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
Delonix Bioworks gets IND clearance for DX-104 in China
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
European Commission approves GSK's Arexvy for adults aged 18 and over
PhotonPharma adds Dr. William Warren to board
GSK wins European Commission approval for Shingrix prefilled syringe
Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio
ECO Animal Health Group secures EU approval for ECOVAXXIN MS